Council for europe portal
Language : en Search
Choose language

Past News

News | 17 December 2020 | Strasbourg, France
The European Directorate for the Quality of Medicines & HealthCare (EDQM) has just released Issue 3 of Pharmeuropa PaedForm, in which the draft text for Phosphate 60 mg/mL Oral Solution is published for public consultation prior to its inclusion in the European Paediatric Formulary. This is the fourth monograph elaborated by the PaedForm Working Party.
News | 16 December 2020 | Strasbourg, France
The European Directorate for the Quality of Medicines & HealthCare (EDQM) has published an analytical method for the determination of polar N-nitrosamines in cosmetic products, which was validated within the European Network of Official Cosmetics Control Laboratories (OCCLs).
News | 16 December 2020 | Strasbourg, France
In June 2018, a manufacturer detected N-nitrosodimethylamine (NDMA) in valsartan active substance batches. This led to multiple regulatory actions addressing the presence of NDMA and other nitrosamine impurities, initially in valsartan but later extended to many other active substances. As 2020 draws to an end, the European Directorate for the Quality of Medicines & HealthCare (EDQM) wishes...
News | 15 December 2020 | Strasbourg, France
A study by the European Network of Official Cosmetics Control Laboratories (OCCLs) indicates that some cosmetic products sold throughout Europe still contain excessive levels of allergy-inducing fragrances. Results showed that 7.7% of samples were non-compliant with legislative requirements due to a missing or false declaration of allergenic fragrance compounds and that 3.1% of products marketed...
News | 15 December 2020 | Strasbourg, France
The European Directorate for the Quality of Medicines & HealthCare (EDQM) has released a webinar illustrating the content of Council of Europe Resolution CM/Res(2020)3 on the implementation of pharmaceutical care for the benefit of patients and health services, which aims to support member states interested in implementing pharmaceutical care in Europe. In line with the above resolution,...
News | 14 December 2020 | Strasbourg, France
The Official Control Authority Batch Release (OCABR) network for human vaccines and the Therapeutic Goods Administration (TGA), Australia have signed a memorandum of understanding (MOU) to increase the exchange and collaboration on common activities related to batch release of human vaccines. 
News | 14 December 2020 | Strasbourg, France
To support the implementation of the newly adopted general chapter on the analysis of N-nitrosamine impurities in active substances (2.5.42., previously listed as 2.4.36.), seven reference standards have been established and are available from the European Directorate for the Quality of Medicines & HealthCare (EDQM).
News | 10 December 2020 | Strasbourg, France
Over the last few years, the European Pharmacopoeia (Ph. Eur.) has been elaborating monographs on medicinal products containing chemically defined active substances, applicable to immediate-release solid dosage forms (tablets, capsules).
News | 08 December 2020 | Strasbourg, France
A conference celebrating 10 years of co-operation between the European Directorate for the Quality of Medicines & HealthCare (EDQM) and the European Commission (EC) in the field of blood transfusion shed light on the challenges faced by blood establishments (BEs) in securing sustainable blood supplies and a resilient blood transfusion sector in Europe.
News | 07 December 2020 | Strasbourg, France
The European Pharmacopoeia (Ph. Eur.) Commission has adopted a new general chapter on the analysis of N-nitrosamine impurities in active substances (2.5.42, previously listed as 2.4.36).
News | 04 December 2020 | Strasbourg, France
The 168th session of the European Pharmacopoeia (Ph. Eur.) Commission took place on 24 and 25 November 2020. At this session, the Commission adopted 114 texts for publication in Ph. Eur. Supplement 10.6, including 101 revised texts and 13 new texts.
News | 02 December 2020 | Strasbourg, France
The EDQM announces the availability of 12 new European Pharmacopoeia (Ph. Eur.) reference standards and 9 replacement batches for Ph. Eur. reference standards.
News | 30 November 2020 | Strasbourg, France
Starting 1 January 2021, specific permits will be required to order R0250000 – Residual solvent solution class 1 CRS. Reference standard R0250000 – Residual solvent solution class 1 CRS contains 2 controlled substances (Carbon tetrachloride and 1,1,1–Trichloroethane).
News | 23 November 2020 | Strasbourg, France
The European Directorate for the Quality of Medicines & HealthCare (EDQM) has released an updated set of pharmacopoeial quality standards for vaccines.
News | 18 November 2020 | Strasbourg, France
Order and shipment deadlines have been established for publications and reference standards, taking into account the closure of the EDQM offices from 23 December 2020 (12 noon CET) to 4 January 2021 (8 a.m. CET).